Intellia Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC NTLA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

239,247

Value ($000)

2,151

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,151	0.0%	239,247	12/31/2025
2025 Q3	11/14/2025	4,167	0.0%	241,282	9/30/2025
2025 Q2	8/14/2025	5,983	0.0%	637,861	6/30/2025
2025 Q1	5/19/2025	3,709	0.0%	521,706	3/31/2025
2024 Q4	2/14/2025	5,634	0.0%	483,185	12/31/2024
2024 Q3	11/14/2024	9,453	0.0%	460,012	9/30/2024
2024 Q2	8/14/2024	11,465	0.0%	512,309	6/30/2024
2024 Q1	5/15/2024	10,444	0.0%	379,638	3/31/2024
2023 Q4	2/14/2024	13,172	0.0%	432,012	12/31/2023
2023 Q3	11/13/2023	12,882	0.0%	407,385	9/30/2023
2023 Q2	8/11/2023	15,606	0.0%	418,725	6/30/2023
2023 Q1	5/15/2023	15,606	0.0%	418,725	3/31/2023
2022 Q4	2/14/2023	13,720	0.0%	393,244	12/31/2022
2022 Q3	11/14/2022	22,556	0.0%	403,075	9/30/2022
2022 Q2	8/12/2022	19,224	0.0%	371,405	6/30/2022
2022 Q1	5/16/2022	23,211	0.0%	319,404	3/31/2022
2021 Q4	2/14/2022	34,123	0.0%	288,589	12/31/2021
2021 Q3	11/15/2021	38,812	0.0%	289,316	9/30/2021
2021 Q2	8/16/2021	44,281	0.0%	273,492	6/30/2021
2021 Q1	5/14/2021	18,554	0.0%	231,191	3/31/2021
2020 Q4	3/1/2021	15,286	0.0%	280,999	12/31/2020
2020 Q3	11/13/2020	1,294	0.0%	65,077	9/30/2020
2020 Q2	8/14/2020	1,260	0.0%	59,941	6/30/2020
2020 Q1	5/15/2020	597	0.0%	48,793	3/31/2020
2019 Q4	2/14/2020	604	0.0%	41,143	12/31/2019